Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Gustoes

V.TLT

Designed in compliance with FDA industry guidelines 2018

BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and...

April 25, 2019

V.TLT

UHN-REB approved Phase II

TORONTO, ON / ACCESSWIRE / April 25, 2019 / Theralase® ...

April 25, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SHORTS COVERED

Longholder99 wrote: I think Ph2 initial results and/or who gets named as our...

April 23, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SHORTS COVERED

shav3 wrote: why hasn't this infection aspect been mentioned/pursued...

April 23, 2019

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SHORTS COVERED

Longholder99 wrote: https://www.google.ca/amp/s/www.evaluate.com/node/14296...

April 23, 2019

V.TLT

RE:RE:RE:SHORTS COVERED

Gustoes wrote:   tomchoco wrote: What do you think an...

April 23, 2019

V.TLT

RE:RE:SHORTS COVERED

tomchoco wrote: What do you think an announcement of Phase 2 will do to the...

April 23, 2019

V.TLT

SHORTS COVERED

$TLT.V THERALASE TECHNOLOGIES INC. 304,755 -268...

April 22, 2019

V.TLT

RE:Abstracts for Theralase Presentations at PD World Congress

Thank you. This conference will be different than others.  Scientists...

April 22, 2019

V.TLT

Displacing platinum complexes

This is a 500m market cap company on the Nasday, TODAY, let alone 6 months...

April 22, 2019

V.TLT

11070-26

Paper 11070-26: Efficacy of Ruthenium Coordination Complex Based...

April 22, 2019

V.TLT

Ruvacare? + ACT? + GMB?

    http://theralase.com/pressrelease/theralase-discovers-new...

April 20, 2019

V.TLT

TLT Chart Analysis from March

https://www.siliconinvestor.com/readmsg.aspx?msgid=32056351 Technicals are...

April 20, 2019

V.TLT

RE:Monte Carlo

This is the Mission,,, who compromises of the full partnership, funding and...

April 20, 2019

V.TLT

Monte Carlo

Shows the complexitites and 10 year evolution Lilhge 2009 http://www...

April 20, 2019

V.TLT

RE:RE:RE:15/492,801 - Status: Notice of Allowance Mailed

Yes, you posted in March. I just included the claim changes and reiterated...

April 18, 2019

V.TLT

RE:RE:RE:RE:Back to the .40's

fredgoodwinson wrote: I`m going to follow the science.After all this is a...

April 18, 2019

V.TLT

Breakout coming

Per Chartologist on Twitter. Still in breakout territory. Healthy pullback...

April 18, 2019

V.TLT

RE:RE:15/492,801 - Status: Notice of Allowance Mailed

This will be a great NR boiler room gonna let it fly for frusty 10 months...

April 18, 2019

V.TLT

RE:15/492,801 - Status: Notice of Allowance Mailed

We have a patent boys and girls!? Report abuse on the FOD crew. Stockhouse...

April 18, 2019

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc. C.AGN

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed ... view more »